Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular Carcinoma

NCT06994572 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)

Interventions

DRUG: CT-01
DRUG: EVEROLIMUS

Sponsor

Captor Therapeutics S.A.